Explore ›
Finding
Finding
adverse
31 of 80 pessary patients (39%) discontinued pessary use or crossed over to surgery, with reasons including discomfort (47%), persistent bulge symptoms (42%), urinary symptoms (32%), and bowel symptoms (21%). Women who discontinued had no significant improvements in any PROMIS functioning domain and only 5% achieved 100% of pretreatment goals compared to 56% in the surgery group (P<0.0001).
| Effect size | 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery |
| Comparator | Surgery group and pessary continuation group |
| Effect summary | adverse; 31 of 80 pessary patients discontinued or crossed over to surgery; 5% of discontinuers achieved 100% goal attainment vs 56% surgery |
| Adverse events | discomfort with pessary 47%, persistent bulge symptoms 42%, urinary symptoms 32%, bowel symptoms 21% |
Connected entities
Interventions
Conditions
Outcomes
Populations
Source
PMC5086295
Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared to pessary for pelvic organ prolapse